Literature DB >> 21815154

Survival analysis of patients with femoral metastases.

Andreas F Mavrogenis1, Elisa Pala, Carlo Romagnoli, Matteo Romantini, Teresa Calabro, Pietro Ruggieri.   

Abstract

BACKGROUND: Previous studies reported on surgical indications for patients with femoral metastases. However, few studies analyzed the spectrum of femoral metastatic presentation. We performed this study to evaluate the survival of patients with femoral metastases, and clarify the treatment of femoral impending and actual pathological fractures.
MATERIALS AND METHODS: We retrospectively studied 110 patients with femoral metastases from various cancers treated with nailing or resection and megaprosthetic reconstruction from 1995 to 2010. The mean follow-up was 18 months. Survival was analyzed with respect to different metastatic presentations regarding gender, type of cancer, number, and location of femoral metastases, type of surgery, and pathological fracture.
RESULTS: Univariate predictors of survival were the pathological fracture and type of surgery; multivariate predictor was only the pathological fracture. Survival was significantly higher in patients with resection compared to nailing, impending compared to actual fracture, solitary metastasis and impending fracture, actual fracture treated with resection, proximal femoral actual fracture and distal femoral impending fracture treated with resection.
CONCLUSIONS: Patients with femoral metastases have better survival when present with impending compared to actual pathological fracture. Although with a higher rate of complications, patients with pathological fractures of the proximal and distal femur may benefit from resection.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21815154     DOI: 10.1002/jso.22061

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  26 in total

1.  What Factors Are Associated With Implant Breakage and Revision After Intramedullary Nailing for Femoral Metastases?

Authors:  Julie J Willeumier; Mustafa Kaynak; Peer van der Zwaal; Sven A G Meylaerts; Nina M C Mathijssen; Paul C Jutte; Panagiotis Tsagozis; Rikard Wedin; Michiel A J van de Sande; Marta Fiocco; P D Sander Dijkstra
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

2.  What Factors Are Associated With Early Mortality in Patients Undergoing Femur Surgery for Metastatic Lung Cancer?

Authors:  June Hyuk Kim; Sung Wook Seo; Chae Hoon Chung
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

3.  C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.

Authors:  Costantino Errani; Monica Cosentino; Giovanni Ciani; Lorenzo Ferra; Patricio A Alfaro; Barbara Bordini; Davide M Donati
Journal:  Int Orthop       Date:  2021-01-04       Impact factor: 3.075

4.  Clinical and functional comparison of dynamic hip screws and intramedullary nails for treating proximal femur metastases in older individuals.

Authors:  Hua Gao; Xiaodong Bai; Wentao Chen; Yadong Li; Liang Zhao; Changgui Liu; Zhenyu Liu; Baojun Wang
Journal:  Chin J Cancer Res       Date:  2020-06       Impact factor: 5.087

5.  CORR Insights®: What Factors Are Associated With Local Metastatic Lesion Progression after Intramedullary Nail Stabilization?

Authors:  Robert L Satcher
Journal:  Clin Orthop Relat Res       Date:  2022-03-17       Impact factor: 4.176

Review 6.  Treatment for long bone metastases based on a systematic literature review.

Authors:  Costantino Errani; Andreas F Mavrogenis; Luca Cevolani; Silvia Spinelli; Andrea Piccioli; Giulio Maccauro; Nicola Baldini; Davide Donati
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-20

7.  Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.

Authors:  David Henry; Saroj Vadhan-Raj; Vera Hirsh; Roger von Moos; Vania Hungria; Luis Costa; Penella J Woll; Giorgio Scagliotti; Geoffrey Smith; Amy Feng; Susie Jun; Roger Dansey; Howard Yeh
Journal:  Support Care Cancer       Date:  2013-10-26       Impact factor: 3.603

8.  BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.

Authors:  Koustav Chatterjee; Saikat De; Sankar Deb Roy; Sushil Kumar Sahu; Arindom Chakraborty; Sandeep Ghatak; Nilanjana Das; Sudipa Mal; Nabanita Roy Chattopadhyay; Piyanki Das; R Rajendra Reddy; Syamantak Mukherjee; Ashok Kumar Das; Zoreng Puii; Eric Zomawia; Yengkhom Indibor Singh; Sam Tsering; Komri Riba; Shanmugam Rajasubramaniam; Amol Ratnakar Suryawanshi; Tathagata Choudhuri
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

9.  The Therapeutic Effect and Clinical Outcome of Immune Checkpoint Inhibitors on Bone Metastasis in Advanced Non-Small-Cell Lung Cancer.

Authors:  Yohei Asano; Norio Yamamoto; Satoru Demura; Katsuhiro Hayashi; Akihiko Takeuchi; Satoshi Kato; Shinji Miwa; Kentaro Igarashi; Takashi Higuchi; Hirotaka Yonezawa; Yoshihiro Araki; Sei Morinaga; Shiro Saito; Takashi Sone; Kazuo Kasahara; Hiroyuki Tsuchiya
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

10.  Thirty-day Postoperative Complications After Surgery For Metastatic Long Bone Disease Are Associated With Higher Mortality at 1 Year.

Authors:  Bas J J Bindels; Quirina C B S Thio; Kevin A Raskin; Marco L Ferrone; Santiago A Lozano Calderón; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2020-02       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.